Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Martinez

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Life Sciences|January 1, 1996
A Gi2alpha antisense oligonucleotide differentiates morphine antinociception, constipation and acute dependence in miceR B Raffa, T L Goode, R P Martinez, et al.
Life Sciences|January 1, 1994
Etonitazene-induced antinociception in mu1 opioid receptor deficient CXBK mice: evidence for a role for mu2 receptors in supraspinal antinociceptionC D Connelly, R P Martinez, J J Schupsky, et al.
NIDA Research Monograph|January 1, 1989
A new analysis of whole-body calorimetry dataT J Lynch, R P Martinez, M B Furman, et al.
Journal of Medicinal Chemistry|February 7, 2001
Alpha(2) adrenoceptor agonists as potential analgesic agents. 2. Discovery of 4-(4-imidazo)-1,3-dimethyl-6,7-dihydro-thianaphthene as a high-affinity ligand for the alpha(2D) adrenergic receptorT M Ross, M C Jetter, M E McDonnell, et al.
Journal of Medicinal Chemistry|March 15, 2000
alpha(2) Adrenoceptor agonists as potential analgesic agents. 2. Discovery of 4-(4-Imidazo)-1,3-dimethyl-6,7-dihydrothianaphthene [corrected] as a high-affinity ligand for the alpha(2D) adrenergic receptorT M Ross, M C Jetter, M E McDonnell, et al.
Journal of Medicinal Chemistry|April 13, 2001
Alpha(2) adrenoceptor agonists as potential analgesic agents. 3. ImidazolylmethylthiophenesR E Boyd, J B Press, C R Rasmussen, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1996
Unexpected antinociceptive effect of the N-oxide (RWJ 38705) of tramadol hydrochlorideR B Raffa, M L Haslego, C A Maryanoff, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 13, 2006
The novel, orally active, delta opioid RWJ-394674 is biotransformed to the potent mu opioid RWJ-413216E E Codd, J R Carson, R W Colburn, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Life Sciences|January 1, 1996
A Gi2alpha antisense oligonucleotide differentiates morphine antinociception, constipation and acute dependence in miceR B Raffa, T L Goode, R P Martinez, et al.
Life Sciences|January 1, 1994
Etonitazene-induced antinociception in mu1 opioid receptor deficient CXBK mice: evidence for a role for mu2 receptors in supraspinal antinociceptionC D Connelly, R P Martinez, J J Schupsky, et al.
NIDA Research Monograph|January 1, 1989
A new analysis of whole-body calorimetry dataT J Lynch, R P Martinez, M B Furman, et al.
Journal of Medicinal Chemistry|February 7, 2001
Alpha(2) adrenoceptor agonists as potential analgesic agents. 2. Discovery of 4-(4-imidazo)-1,3-dimethyl-6,7-dihydro-thianaphthene as a high-affinity ligand for the alpha(2D) adrenergic receptorT M Ross, M C Jetter, M E McDonnell, et al.
Journal of Medicinal Chemistry|March 15, 2000
alpha(2) Adrenoceptor agonists as potential analgesic agents. 2. Discovery of 4-(4-Imidazo)-1,3-dimethyl-6,7-dihydrothianaphthene [corrected] as a high-affinity ligand for the alpha(2D) adrenergic receptorT M Ross, M C Jetter, M E McDonnell, et al.
Journal of Medicinal Chemistry|April 13, 2001
Alpha(2) adrenoceptor agonists as potential analgesic agents. 3. ImidazolylmethylthiophenesR E Boyd, J B Press, C R Rasmussen, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1996
Unexpected antinociceptive effect of the N-oxide (RWJ 38705) of tramadol hydrochlorideR B Raffa, M L Haslego, C A Maryanoff, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 13, 2006
The novel, orally active, delta opioid RWJ-394674 is biotransformed to the potent mu opioid RWJ-413216E E Codd, J R Carson, R W Colburn, et al.
Pageof 2